Mark Massaro
Stock Analyst at BTIG
(3.47)
# 848
Out of 5,241 analysts
176
Total ratings
40.85%
Success rate
6.78%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $0.947 | +163.99% | 6 | May 15, 2026 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $4 | $0.8393 | +376.59% | 11 | May 14, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $50 → $40 | $19.20 | +108.33% | 7 | May 13, 2026 | |
| XGN Exagen | Maintains: Buy | $9 → $8 | $3.73 | +114.48% | 8 | May 12, 2026 | |
| NTRA Natera | Maintains: Buy | $260 → $250 | $196.04 | +27.52% | 17 | May 11, 2026 | |
| PSNL Personalis | Maintains: Buy | $13 → $11 | $7.04 | +56.25% | 6 | May 11, 2026 | |
| TEM Tempus AI | Maintains: Buy | $90 → $80 | $45.53 | +75.71% | 8 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintains: Buy | $38 → $32 | $14.96 | +113.90% | 2 | May 8, 2026 | |
| BLLN BillionToOne | Maintains: Buy | $140 → $130 | $82.29 | +57.98% | 4 | May 7, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterates: Buy | $22 | $12.96 | +69.75% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.68 | +70.94% | 5 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $90 | $42.13 | +113.62% | 9 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 | $2.70 | +48.15% | 2 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $28 | $20.53 | +36.39% | 7 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $9 → $5 | $7.36 | -32.07% | 8 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $145 | $98.19 | +47.67% | 8 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $830 → $800 | $546.49 | +46.39% | 3 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $160 | $78.92 | +102.74% | 4 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.04 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.17 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $8.39 | +150.30% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.72 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $141.68 | +111.74% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $190.39 | -41.17% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $253.69 | -34.96% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $11.38 | +602.99% | 9 | Sep 10, 2018 |
Lucid Diagnostics
May 15, 2026
Reiterates: Buy
Price Target: $2.5
Current: $0.947
Upside: +163.99%
MDxHealth
May 14, 2026
Maintains: Buy
Price Target: $7 → $4
Current: $0.8393
Upside: +376.59%
Castle Biosciences
May 13, 2026
Maintains: Buy
Price Target: $50 → $40
Current: $19.20
Upside: +108.33%
Exagen
May 12, 2026
Maintains: Buy
Price Target: $9 → $8
Current: $3.73
Upside: +114.48%
Natera
May 11, 2026
Maintains: Buy
Price Target: $260 → $250
Current: $196.04
Upside: +27.52%
Personalis
May 11, 2026
Maintains: Buy
Price Target: $13 → $11
Current: $7.04
Upside: +56.25%
Tempus AI
May 8, 2026
Maintains: Buy
Price Target: $90 → $80
Current: $45.53
Upside: +75.71%
Caris Life Sciences
May 8, 2026
Maintains: Buy
Price Target: $38 → $32
Current: $14.96
Upside: +113.90%
BillionToOne
May 7, 2026
Maintains: Buy
Price Target: $140 → $130
Current: $82.29
Upside: +57.98%
Adaptive Biotechnologies
May 6, 2026
Reiterates: Buy
Price Target: $22
Current: $12.96
Upside: +69.75%
May 6, 2026
Reiterates: Buy
Price Target: $8
Current: $4.68
Upside: +70.94%
May 5, 2026
Maintains: Buy
Price Target: $170 → $90
Current: $42.13
Upside: +113.62%
May 1, 2026
Upgrades: Buy
Price Target: $4
Current: $2.70
Upside: +48.15%
Apr 29, 2026
Maintains: Buy
Price Target: $26 → $28
Current: $20.53
Upside: +36.39%
Mar 12, 2026
Maintains: Sell
Price Target: $9 → $5
Current: $7.36
Upside: -32.07%
Feb 20, 2026
Maintains: Buy
Price Target: $140 → $145
Current: $98.19
Upside: +47.67%
Feb 3, 2026
Maintains: Buy
Price Target: $830 → $800
Current: $546.49
Upside: +46.39%
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $78.92
Upside: +102.74%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.04
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.17
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $8.39
Upside: +150.30%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.72
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $141.68
Upside: +111.74%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $190.39
Upside: -41.17%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $253.69
Upside: -34.96%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $11.38
Upside: +602.99%